Evidence map›Paper›PMID 40303104›Full record

ArticleTransboundary and emerging diseases2024

Genomic Characterization of Extended-Spectrum

Muhammad Shoaib, Minjia Tang, Furqan Awan, Amjad Islam Aqib, Ruochen Hao, Saad Ahmad, Shengyi Wang, Ruofeng Shang, Wanxia Pu

Abstract read
In one paragraph

Article in Transboundary and emerging diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Whole Genome Sequencing Reveals Genetic Variability ofAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Novel ST3871Microbiology spectrum · 2026
    Article
  6. Article
  7. Draft genome sequence of multidrug-resistantMicrobiology resource announcements · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Virulence and Antibiotic Resistance of aEPEC/STECPathogens (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Pathogenomic Characterization of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muhammad ShoaibKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0001-8695-1840
Minjia TangKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0002-7156-954X
Furqan AwanDepartment of Epidemiology and Public Health, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.ORCID https://orcid.org/0000-0002-7454-1323
Amjad Islam AqibDepartment of Medicine, Cholistan University of Veterinary and Animal Sciences, Bahawalpur 63100, Pakistan.ORCID https://orcid.org/0000-0001-7618-3948
Ruochen HaoKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0009-0003-9736-7377
Saad AhmadKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0003-0588-6771
Shengyi WangKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0001-5195-5059
Ruofeng ShangKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0003-2814-0761
Wanxia PuKey Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, Lanzhou 730050, China.ORCID https://orcid.org/0000-0002-4607-5855

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthropogenic activities in the environment affect the ecosystem and can play an important role in selecting and spreading antibiotic-resistant bacteria (ARB) and genes (ARGs). The dairy farm environment may serve as a hotspot and reservoir for exchanging and spreading ARGs, but studies are scarce. Here, we investigated and characterized the extended-spectrum

Indexed as

beta-LactamasesEscherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial AgentsCattleChinaDairyingEscherichia coli ProteinsFarmsAnti-Bacterial Agentsbeta-LactamasesEscherichia coli Proteinsbioinformatics analysisblaOXA−1-catB3-arr-3 gene arraydairy farm environmentEscherichia coliwhole genome sequencing

Identifiers

PMID40303104
PMCPMC12017223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.